Torrent Pharmaceuticals Limited

NSE:TORNTPHARM.NS

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

💻 Telehealth

Location

India

Market Cap

USD 12.37 B

Share Price

USD 36.56

Avg Daily Volume

343,112

Change (1 day)

0.20%

Change (1 year)

7.02%

Change (YTD)

-6.86%

Torrent Pharmaceuticals Limited Free Cash Flow for the year ending March 31, 2025: USD 231.00 M

Torrent Pharmaceuticals Limited Free Cash Flow is USD 231.00 M for the year ending March 31, 2025, a -32.00% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Torrent Pharmaceuticals Limited Free Cash Flow for the year ending March 31, 2024 was USD 339.68 M, a 55.62% change year over year.
Torrent Pharmaceuticals Limited Free Cash Flow for the year ending March 31, 2024 was USD 339.68 M, a 0.00% change year over year.
Torrent Pharmaceuticals Limited Free Cash Flow for the year ending March 31, 2023 was USD 218.28 M, a 3.56% change year over year.
Torrent Pharmaceuticals Limited Free Cash Flow for the year ending March 31, 2022 was USD 210.78 M, a -7.89% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Free Cash Flow	Operating Cash Flow	Capital Expenditure	Net Cash Used For Investing Activities

NSE: TORNTPHARM.NS

Torrent Pharmaceuticals Limited

CEO	Mr. Sanjay Gupta
IPO Date	July 1, 2002
Location	India
Headquarters	Torrent House
Employees	15,718
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies 💻 Telehealth

Description

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.